Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm

Cardiovascular Research

Volumn 43, Issue 4, 1999, Pages 1029-1039

  Shimokawa, Hiroaki ^a   Seto, Minoru ^b   Katsumata, Naoki ^a   Amano, Mutsuki ^c   Kozai, Toshiyuki ^a   Yamawaki, Tohru ^a   Kuwata, Kouichi ^a   Kandabashi, Tadashi ^a   Egashira, Kensuke ^a   Ikegaki, Ichiro ^b   Asano, Toshio ^b   Kaibuchi, Kozo ^c   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b ASAHI CHEMICAL INDUSTRY CO   (Japan)

^c NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Calcium; Coronary vasospasm; Myosin light chain; Rho kinase

Indexed keywords

CALCIUM; FASUDIL; MYOSIN ADENOSINE TRIPHOSPHATASE; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY SPASM; IMMUNOBLOTTING; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE CONTRACTION; SWINE;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CORONARY VASOSPASM; CORONARY VESSELS; ENZYME INHIBITORS; INTERLEUKIN-1; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MYOSIN LIGHT CHAINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SEROTONIN; SIGNAL TRANSDUCTION; SWINE; VASODILATION;

EID: 0032877847     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00144-3     Document Type: Article

References (35)

1. Maseri A., Severi S., DeNes D.M., et al. 'Variant' angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia: pathogenic mechanisms, estimated incidence and clinical and coronary angiographic findings in 138 patients. Am J Cardiol. 42:1978;1019-1035.
2. Shimokawa H., Tomoike H., Nabeyama S., et al. Coronary artery spasm induced in atherosclerotic miniature swine. Science. 221:1983;560-562.
3. Shimokawa H., Ito A., Fukumoto Y., et al. Chronic treatment with interleukin-1β induces coronary intimal lesions and vasospastic responses in pigs in vivo: the role of platelet-derived growth factor. J Clin Invest. 97:1996;769-776.
4. Ito A., Shimokawa H., Kadokami T., et al. Tyrosine kinase inhibitor suppresses coronary arteriosclerotic changes and vasospastic responses induced by chronic treatment with interleukin-1β in pigs in vivo. J Clin Invest. 96:1995;1288-1294.
5. Ito A., Shimokawa H., Nakaike R., et al. Role of protein kinase C-mediated pathway in the pathogenesis of coronary artery spasm in a swine model. Circulation. 90:1994;2425-2431.
6. Kadokami T., Shimokawa H., Fukumoto Y., et al. Coronary artery spasm does not depend on the intracellular calcium store but is substantially mediated by the protein kinase C-mediated pathway in a swine model with interleukin-1β in vivo. Circulation. 94:1996;190-196.
7. Katsumata N., Shimokawa H., Seto M., et al. Enhanced myosin light chain phosphorylations as a central mechanism of coronary artery spasm in a swine model with interleukin-1β Circulation. 96:1997;4357-4363.
8. Asano T., Ikegaki I., Satoh S., et al. Mechanism of action of a novel antivasospasm drug, HA1077. J Pharmacol Exp Ther. 241:1987;1033-1040.
9. Seto M., Sasaki Y., Sasaki Y., Hidaka H. Effect of HA1077, a protein kinase inhibitor, on myosin phosphorylation and tension in smooth muscle. Eur J Pharmacol. 195:1991;267-272.
10. Kitazawa T., Masuo M., Somlyo A.P. G protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc Natl Acad Sci USA. 88:1991;9307-9310.
11. Hirata K., Kikuchi A., Sasaki T., et al. Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem. 267:1992;8719-8722.
12. Noda M., Yasuda-Fukazawa C., Moriishi K., et al. Involvement of rho in GTP gamma S-induced enhancement of phosphorylation of 20 kDa myosin light chain in vascular smooth muscle cells: inhibition of phosphatase activity. FEBS Lett. 367:1995;246-250.
13. 2+ sensitization of smooth muscle. Proc Natl Acad Sci USA. 93:1996;1340-1345.
14. Kimura K., Ito M., Amano M., et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science. 273:1996;245-248.
15. Amano M., Ito M., Kimura K., et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem. 271:1996;20246-20249.
16. Chihara K., Amano M., Nakamura N., et al. Cytoskeletal rearrangements and transcriptional activation of c-fos serum response element by Rho-kinase. J Biol Chem. 272:1997;25121-25127.
17. Kureishi Y., Kobayashi S., Amano M., et al. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem. 272:1997;12257-12260.
18. Amano M., Chihara K., Nakamura N., et al. Myosin II activation promotes neurite retraction during the action of Rho and Rho-kinase. Genes Cells. 3:1998;177-188.
19. Arai M., Sasaki Y., Nozawa R. Inhibition by the protein kinase inhibitor HA1077 of the activation of NADPH oxidase in human neutrophils. Biochem Pharmacol. 46:1993;1487-1490.
20. Seto M., Sasaki Y., Sasaki Y. Alteration in the myosin phosphorylation pattern of smooth muscle by phorbol ester. Am J Physiol. 259:1990;C769-C774.
21. Sakurada K., Ikuhara T., Seto M., Sasaki Y. An antibody for phosphorylated myosin light chain of smooth muscle: Application to a biochemical study. J Biochem. 115:1994;18-21.
22. Sakurada K., Seto M., Sasaki Y. Dynamics of myosin light chain phosphorylation at Ser19 and Thr18/Ser19 in smooth muscle cells in culture. Am J Physiol. 274:1998;C1563-C1572.
23. Matsuura Y., Possee R.D., Overton H.A., Bishop D.H. Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J Gen Virol. 68:1987;1233-1250.
24. Matsui T., Amano M., Yamamoto T., et al. Rho-associated kinase, a novel serine/threonine kinase, as a putative target for the small GTP binding protein Rho. EMBO J. 15:1996;2208-2216.
25. Somlyo A.P., Somlyo A.V. Signal transduction and regulation in smooth muscle. Nature (Lond.). 372:1994;231-236.
26. Ikebe M., Hartshorne D.J., Elzinga M. Phosphorylation of the 20,000-dalton light chain of smooth muscle myosin by the calcium-activated, phospholipid-dependent protein kinase. Phosphorylation sites and effects of phosphorylation. J Biol Chem. 262:1987;9569-9573.
27. Kamm K.E., Stull J.T. Regulation of smooth muscle contractile elements by second messengers. Annu Rev Physiol. 51:1989;299-313.
28. Murphy R.A. What is special about smooth muscle? The significance of covalent cross bridge regulation. FASEB J. 8:1994;311-318.
29. Ikebe M., Hartshorne D.J. Phosphorylation of smooth muscle myosin at two distinct sites by myosin light chain kinase. J Biol Chem. 260:1985;10027-10031.
30. Seto M., Sakurada K., Kamm K.E., Stull J.T., Sasaki Y. Myosin light chain diphosphorylation is enhanced by growth promotion of cultured smooth muscle cells. Eur J Physiol. 432:1996;7-13.
31. Alessi D., MacDougall L.K., Sola M.M., Ikebe M., Cohen P. The control of protein phosphatase-1 by targeting subunits. The major myosin phosphatase in avian smooth muscle is a novel form of protein phosphatase-1. Eur J Biochem. 210:1992;1023-1035.
32. Shimizu H., Ito M., Miyahara M., et al. Characterization of the myosin-binding subunit of smooth muscle myosin phosphatase. J Biol Chem. 269:1994;30407-30411.
33. Chen Y., Chen M.X., Alessei D.R., et al. Molecular cloning of cDNA encoding the 110 kDa and 21 kDa regulatory subunits of smooth muscle protein phosphatase 1M. FEBS Lett. 367:1994;246-250.
34. Eto M., Ohmori T., Suzuki M., Furuya K., Morita F. A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C: isolation from porcine aorta media and characterization. J Biochem. 118:1995;1104-1107.
35. Uehata M., Ishizaki T., Satoh H., et al. Calcium sensitization of smooth muscle mediated by a Rho-associated kinase in hypertension. Nature. 389:1997;990-994.